Clarifications on preferential share swap for Vinpai acquisition

Fund Raising View source PDF Explain this filing

CAMLINFINE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.5%Reaction day

₹183.90

prior close

₹185.70

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.0%-1.5% vs market

Specialty Chemicals peers, median of 85sector+0.0%-0.5% vs sector

On the reaction day the stock moved 1.5 pts less than Nifty Microcap 250 and 0.5 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.4

10m

-1.4

15m

-1.6

30m

-1.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.5+1.0-1.5+0.0-0.5

Next day

+3.4+2.0+1.3+1.0+2.4

+8.2+1.6+6.7+0.9+7.3

+6.0+1.2+4.8+0.5+5.6

+6.8+1.6+5.1-0.5+7.3

+6.4+1.9+4.6-0.1+6.6

+7.1+2.1+5.0-0.8+8.0

15d

-7.5+1.0-8.5-3.8-3.7

-13.6+0.2-13.8-5.3-8.3

-14.6-3.1-11.5-8.6-6.0

-22.8-10.9-11.9-16.7-6.1

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 85Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Camlin Fine Sciences issued a corrigendum after NSE and BSE sought clarifications on a proposed share swap. Shareholders will vote on issuing up to 41,06,181 shares at ₹247.69 each in exchange for 27,23,316 Vinpai shares, representing 78.68% of Vinpai, valued at about €98.04 million. The issue raises no cash, gives the investors 2.10% of enlarged capital and does not change control. Members may update votes by 5 pm IST on October 29, 2025.

Likely market impact

Existing holders' stake would dilute by about 2.1%. The deal would add exposure to Vinpai's €9.2 million 2024 sales, but approval is pending.